Non-Invasive Neuron Stimulation With Acoustic Side-Effect Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing non-invasive vibrotactile stimulation treatments for neurological disorders suffer from undesired acoustic side effects, such as sound waves generated by vibrotactile stimulation elements, which reduce patient compliance due to annoyance.
Innovation Solution
A medical treatment device and method that simultaneously administers both acoustic and non-acoustic stimuli, such as vibrotactile and acoustic stimuli, to suppress pathologically synchronous neuronal activity without invasive procedures, using a non-invasive stimulation unit with a control unit to actuate multiple elements on the body to desynchronize neuronal firing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If non-invasive vibrotactile stimulation elements are actuated to suppress pathologically synchronous neuronal activity, then therapeutic effect is improved, but acoustic stimuli are generated as harmful side effects
Solution Approach 1:
The harmful acoustic stimulus is extracted and separated from the useful vibrotactile stimulation. The patent implements this by providing at least one acoustic stimulus counteracting the acoustic stimulus generated by the vibrotactile stimulation element, effectively removing the harmful side effect while preserving the therapeutic benefit.
Solution Approach 2:
The patent converts the harmful acoustic stimulus into a beneficial treatment component by administering a counteracting acoustic stimulus that specifically targets and suppresses the pathological synchronous activity in the brain, thereby transforming the side effect into part of the therapeutic mechanism.
2Reliability
If deep brain stimulation is performed to suppress pathologically synchronous activity, then therapeutic effect is improved, but surgical risk increases
Solution Approach 1:
The patent replaces the invasive mechanical deep brain stimulation system with a non-invasive vibrotactile stimulation system that acts on the skull surface. This substitution eliminates surgical procedures and associated risks while maintaining therapeutic effectiveness through external vibration applied to specific skull regions.
Solution Approach 2:
The patent introduces the skull surface as an intermediary medium to transmit therapeutic vibrations from external stimulation elements to the underlying brain tissue. This intermediary approach allows non-invasive delivery of therapeutic effects that previously required direct brain tissue intervention.
3Reliability
If L-DOPA pharmacological treatment is administered, then therapeutic effect is improved, but long-term side effects increase
Solution Approach 1:
The patent replaces pharmacological treatment with a physical stimulation approach using vibrotactile elements. This substitution eliminates the need for chemical substances like L-DOPA, thereby avoiding long-term side effects such as dyskinesia and nausea while providing alternative therapeutic mechanisms through mechanical vibration of neuronal tissue.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Effectively suppresses pathological synchronous neuronal activity while minimizing acoustic side effects, improving treatment efficacy and patient compliance by desynchronizing neuronal activity through coordinated reset stimulation.
Implementation Method 1
sound waves generated upon actuation of the stimulation elements which are conducted to the patient's inner ear through air and bone conduction
Implementation Method 2
sound waves generated upon actuation of the stimulation elements which are conducted to the patient's inner ear through air and bone conduction
Implementation Method 3
non-invasive vibrotactile stimulation treatments are known to counteract Parkinsonian signs
Data Source
AI summary
The present invention pertains to a medical treatment device (10) for stimulating neurons of a patient to suppress a pathologically synchronous activity of the neurons. The device (10) comprises a non-invasive stimulation unit (12) configured for simultaneously administering at least one acoustic stimulus and at least one non-acoustic stimulus to a patient's body, each of which is configured to suppress the pathologically synchronous activity when being administered to the patient's body.


